Piramal Pharma Solutions (PPS), a leading global Contract Development and Manufacturing Organization (CDMO) and part of ...

Piramal's global Contract Development and Manufacturing Organization plans to more than double the facility’s capacity by Q1 ...

Piramal Pharma Solutions Inc. today announced plans to expand its current Lexington operations with a nearly $80 million ...

Piramal Pharma Solutions invests $80 million in Lexington facility expansion to meet growing demand in injectables market.

As the efficiency and efficacy of injectable treatment options improve, more patients are expected to benefit from advanced therapies.

Piramal Pharma Solutions, is investing $80 million to expand its Lexington facility, doubling capacity by Q1 2027 to meet ...

The expansion will equip the Lexington site with an additional 24,000 square feet of manufacturing space, a new lab, and ...

Piramal Pharma Solutions (PPS), a leading global Contract Development and Manufacturing Organization (CDMO) and part of Piramal Pharma has unveiled an $80M investment plan to expand its Lexington, ...

The investment has been financed through bank loans and internal accruals, and aims to enhance site’s capacity to meet rising ...

Mumbai: Piramal Pharma has received an Establishment Inspection Report (EIR) from the US Food and Drug Administration (US FDA ...

Indian benchmark indices Nifty 50 and Sensex ended the previous trade session lower. Nifty 50 ended at 25,810.85, while ...

Stocks including NTPC, Tata Power, IRCTC, Blue Dart, Andhra Cements, Bank of Maharashtra, Piramal Pharma and more will be the ...